Absinthe, Absinthism and Thujone–New Insight into the Spirit's Impact on Public Health

Abstract

Absinthe, a strong alcoholic aperitif, is notorious for containing the compound 'thujone', which has been commonly regarded as its 'active ingredient'. It has been widely theorized that the thujone content of vintage absinthe made it harmful to public health, and caused the distinct syndrome absinthism, which was extensively described in the literature prior to the spirit's ban in 1915. The interdisciplinary research presented in this paper shows that 1) absinthism cannot be distinguished from common alcoholism in the medical research literature of the time, and that 2) due to the physical chemistry of the distillation process, the thujone content of vintage absinthe was considerably lower than previously estimated and corresponds to levels generally recognized as safe, as proven by analyses of absinthes from the pre-ban era. Due to the re-legalization of absinthe in the European Union and more recently in the United States, potential public health concerns have re-emerged, not expressly based on worries about thujone content or absinthism, but on alcohol-related harm and youth protection issues, exacerbated by marketing strategies promoting absinthe using false and discredited claims pertaining to thujone and stubbornly persistant myths.

Full text

32 The Open Addiction Journal, 2010, 3, 32-38
1874-9410/10 2010 Bentham Open
Open Access
Absinthe, Absinthism and Thujone – New Insight into the Spirit's Impact
on Public Health
Dirk W. Lachenmeier*,1, David Nathan-Maister2, Theodore A. Breaux3, Jean-Pierre Luauté4 and
Joachim Emmert5
1Chemisches und Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3, D-76187 Karlsruhe,
Germany
2Oxygenee Ltd, P.O. Box 340, Burgess Hill, RH15 5AP, UK
3Jade Liqueurs, L.L.C., 3588 Brookfield Rd, Birmingham, Alabama, 35226, USA
425 Rue de la République, 26100 Romans, France
5Perreystrasse 34, D-68219 Mannheim, Germany
Abstract: Absinthe, a strong alcoholic aperitif, is notorious for containing the compound ‘thujone’, which has been
commonly regarded as its ‘active ingredient’. It has been widely theorized that the thujone content of vintage absinthe
made it harmful to public health, and caused the distinct syndrome absinthism, which was extensively described in the
literature prior to the spirit’s ban in 1915. The interdisciplinary research presented in this paper shows that 1) absinthism
cannot be distinguished from common alcoholism in the medical research literature of the time, and that 2) due to the
physical chemistry of the distillation process, the thujone content of vintage absinthe was considerably lower than
previously estimated and corresponds to levels generally recognized as safe, as proven by analyses of absinthes from the
pre-ban era. Due to the re-legalization of absinthe in the European Union and more recently in the United States, potential
public health concerns have re-emerged, not expressly based on worries about thujone content or absinthism, but on
alcohol-related harm and youth protection issues, exacerbated by marketing strategies promoting absinthe using false and
discredited claims pertaining to thujone and stubbornly persistant myths.
Keywords: Absinthe, absinthism, thujone, alcohol, ethanol, alcoholic beverages, spirits, alcohol abuse, alcohol-related
disorders.
INTRODUCTION
Absinthe is a strong alcoholic aperitif traditionally
distilled from alcohol and herbs or cold-compounded from
herbal extracts, chief amongst them common or ‘grande’
wormwood (Artemisia absinthium L.), green anise
(Pimpinella anisum L.) and Florence fennel (Foeniculum
vulgare Mill.), but also most often including three other
herbs: Roman or ‘petite’ wormwood (Artemisia pontica L.),
hyssop (Hyssopus officinalis L.), and melissa or lemon balm
(Melissa officinalis L.).
The popular belief about absinthe is that it is an illicit
drug, or at least is possessive of qualities that render it
similar to such drugs in effect. Central to this belief is a
substance called ‘thujone’ (Fig. 1), which is a natural
constituent of Artemisia sp., and usually regarded as its
‘active’ ingredient. Thujone was said to be harmful to public
health, causing ‘absinthism’, a syndrome distinct from
alcoholism, characterized by epileptic fits and rapid mental
and physical deterioration.
*Address correspondence to this author at the Chemisches und
Veterinäruntersuchungsamt (CVUA) Karlsruhe, Weissenburger Strasse 3,
D-76187 Karlsruhe, Germany; Tel: +49-721-926-5434; Fax: +49-721-926-
5539; E-mail: Lachenmeier@web .de
O
Thujone
O
Thujone
O
Fenchone
O
Pinocamphone
Fig. (1). Chemical structures of terpenes naturally occurring in
absinthe: thujone from wormwood, fenchone from fennel, and
pinocamphone from hyssop.
In this article, the authors systematically study these
prejudices about absinthe, and provide scientific evidence
from a multidisciplinary perspective to explain the popular
misconceptions that absinthe caused hallucinations, drove

Absinthe, Absinthism and Thujone The Open Addiction Journal, 2010, Volume 3 33
men ‘mad’, threw them into epileptic fits, and even made
van Gogh slice off his ear.
HISTORY OF ABSINTHE
High quality absinthes are always distilled from whole
herbs rather than compounded from commercial essences,
and have a deliciously complex herbal and floral character,
with an underlying bitterness contributed by the
wormwood(s). Well-made absinthes are naturally colored
and generally pale green, but ‘louche’, or turn milky, when
water is added. This is caused by the essential oils
precipitating out of the solution as the alcohol is diluted.
Clear absinthes – often referred to as ‘La Bleue’ or ‘La
Blanche’, are historically popular in Switzerland, and are
crafted without the final coloring step [1, 2].
While infusions of wormwood date back to Roman times
and earlier [3], the specific green-tinged distillation of
wormwood, anise and fennel that constitutes the modern
liquor absinthe seems to have originated in western
Switzerland in the second half of the 18th century. Legend
has it, that the inventor of the drink was Dr. Pierre Ordinaire,
who in the 1780’s, shortly before the French revolution,
travelled around the Val de Travers near Couvet in
Switzerland, and produced the first distilled absinthe,
initially as an all-purpose remedy or cure-all. It would
eventually be nicknamed ‘La Fée Verte’ – ‘The Green Fairy’
– and this name stuck throughout absinthe's heyday. While
credence is generally given to the legend of Dr. Ordinaire,
more recent research has uncovered multiple references to
the liquor in regional records from at least the 1760’s
onwards, and it seems more probable that Dr. Ordinaire was
simply an enthusiastic early advocate of the drink, rather
than necessarily its original creator. Absinthe was
recommended for the treatment of epilepsy, gout, kidney
stones, colic, headaches and worms. Dr. Ordinaire's absinthe
recipe aroused the interest of a gentleman named Major
Dubied, who saw its possibilities not just as a patent
medicine, but as an apéritif. Dubied purchased what was
reputed to be Ordinaire’s original formula at the beginning
of the 19th century and began commercial production [4].
An original 1794 recipe for absinthe is shown in Fig. (2) [5].
By 1805, the Pernod Fils absinthe company was set up in
Pontarlier in the Doubs region, and run by Dubied's son-in-
law, Henri-Louis Pernod. Initially there were just two stills
producing only 16 liters of absinthe per day, but Pernod Fils
very soon went from strength to strength. By 1850, when
Louis died, the factory had 26 stills producing 20,000 liters
per day [6].
The popularity of absinthe spread further as it was used
as a fever preventative by French troops fighting in Algeria
from 1844 to 1847. Mixed with wine or water it was
believed to kill germs and fend off dysentery. When the
troops of the Bataillon d'Afrique returned to France, they
brought with them their taste for the refreshingly bitter drink,
and absinthe became popular in bars and bistros all over
France [4].
Licensing laws were relaxed during the 1860's, which
resulted in a proliferation of new bars, cabarets and cafés –
more than 30,000 existed in Paris by 1869, and 5 p.m.
signified ‘l'Heure Verte’ – ‘the Green Hour’ – in almost
every one. The cafés were an extremely popular place to
socialize, since most of Paris' citizens were living in cramped
apartments, often in squalor and poverty [4].
Fig. (2). Original 1794 recipe of absinthe. For 18 pots of eau-de-vie
(approximately 34 litres), a large bucket of common wormwood
(Artemisia absinthium), some mint, two handfuls of lemon balm
and two of green anise, the same amount of fennel, some calamus.
To colour: a handful of roman wormwood (Artemisia pontica) and
the same amount of hyssop (Reproduced with permission from
Delachaux [5]).
Absinthe hit its peak during the years from 1880–1910,
when it fell dramatically in price, becoming accessible to all
parts of society and rivaling wine as the most popular drink
in France. In the 1870’s phylloxera had ravaged the
vineyards of France, substantially increasing the cost of
wine, and opening the door to the widespread use of lower
cost alcohols derived from sugar beet or grain in the
production of absinthe. This lowering of production costs,
coupled with increased demand due to the shortage of wine,
was the reason behind the explosive growth in popularity of
the drink, but also sowed the seeds of its downfall. In 1874,
France consumed 700,000 liters of absinthe, but by 1910, the
figure had exploded to 36,000,000 liters of absinthe per year.
It was a quintessential part of Belle Époque French society
[4].
In the 1860's, there was for the first time concern about
the results of chronic abuse of absinthe. Chronic use of
absinthe was claimed to produce a syndrome, called
‘absinthism’, which was characterized by addiction,
hyperexcitability, epileptic fits and hallucinations [7].
ABSINTHISM WAS MISDIAGNOSED ALCOHOLISM
The first report describing absinthism as a syndrome
distinct from alcoholism appeared in 1859 in the doctoral
thesis ‘Considerations Générales sur l’Alcoolisme, et plus
particulièrement des Effects Toxiques Produits sur l’Homme
par la Liqueur d’Absinthe’ by Auguste Motet [8].

34 The Open Addiction Journal, 2010, Volume 3 Lachenmeier et al.
The characterisation of absinthism as a distinct syndrome
was further developed by the eminent French researcher Dr
Valentin Magnan, the chief physician at the asylum of
Sainte-Anne in Paris, in a series of influential papers [9].
Magnan attributed the epileptic seizures and general delirium
observed in long term absinthe drinkers to wormwood
essence in absinthe in particular, rather than to alcohol in
general [10]. A historical survey [9] showed that Magnan
was swayed by specific anecdotal reports from which he
inferred the general principle. Magnan’s convictions were
further supported by the discovery he made, while serving as
an intern under L.-V. Marcé, on the highly convulsive effect
of the essential oil of wormwood on animals [10]. Fig. (3)
shows a satirical drawing of such animal experiments. The
results of their experiments gained renown as they were
presented by Marcé and read by Claude Bernard himself
[11]. Although Magnan was a firm supporter of the doctrine
of ‘médecine expérimentale’, the clinical confirmation he
drew ignored the fact that the actual concentration of
wormwood essential oil in traditionally distilled absinthe
was small. Matters were not helped by semantic confusion –
Anglophones generally use the word ‘wormwood’ when
referring to the plant or its essential oil, and the word
‘absinthe’ when referring to the alcoholic aperitif. In French,
‘absinthe’ refers to the plant and its oils, and/or the drink. So
experimental results directly related only to wormwood oil
were, in the popular mind, easily confused as referring to the
popular aperitif itself [7]. Magnan further used clinical
observations of dogs treated with absinthe oil to infer, as in
humans, the presence of hallucinations. Magnan’s
allegations about absinthe were immediately challenged in
France and particularly in England, but the distinction
between the effects of absinthe and of alcohol in general
remained for him indisputable. In 1874 he published an
English article in the Lancet expounding upon his views
[12]. Magnan, who was widely eminent in his field – he is
still regarded today as one of the fathers of French psychiatry
– firmly battled against all critics.
Additionally, during the late 19th and early 20th centuries,
various temperance movements were active in both France
and Switzerland, all of whom targeted absinthe with
particular vehemence. Due to its high alcoholic strength,
rising popularity and simultaneously decreasing shelf price
(with industrial, adulterated brands being seductively cheap),
absinthe became an obvious poster child for the dangers of
alcohol. The word ‘absinthism’ soon came to lose its specific
meaning. Absinthism and alcoholism were confused, and
alcohol dependent people were simply deemed ‘absinthe
drinkers’. This confusion also seems to have been
deliberately encouraged by the wine-growing industry,
struggling to regain market share after the ravages of
phylloxera. Wine was believed to be healthy and natural,
since it came from the land and was a time-honored
tradition, not to mention a major source of revenue.
Absinthe, however, was oftentimes made with industrial
alcohol (especially the cheaper brands), and so it is no
surprise that it was targeted from both the temperance
movement and the wine lobby, leading to the absinthe
prohibition in many European countries at the beginning of
the 20th century [4].
Fig. (3). Satirical drawing of the animal experiments with dogs,
which were conducted for proofing the syndrome absinthism
(Reproduced with permission from Nathan-Maister [4]).
DISTILLATION TECHNOLOGY DISPROVES THE
THUJONE CONNECTION
Besides the lack of proof about absinthism in the medical
literature [7, 9], the physicochemical characteristics of the
distillation and manufacturing processes of absinthe have to
be considered in the evaluation of thujone as potentially
causative agent for absinthe’s effects [13].
The production technique utilized by absinthe distillers of
the Belle Époque is described in detail, both in distillers’
promotional literature [14] and throughout various third-
party treatises from the period [15]. Likewise, the equipment
used for the process is described in the same texts, as well as
depicted in numerous photographs of distillation salons from
the most prestigious houses. In fact, some of these original
pieces of equipment remain in commercial service to the
present day (Fig. 4).
The basic process consists of a simple fractional re-
distillation that involves the use of a large pot still designed
for the purpose. The procedure calls for the maceration of
whole herbs in a neutral spirit (typically 85+% ethanol) for a
period of 12-24 hours, followed by the addition of a volume
of water, which is followed by distillation. The distillate is
always recovered in fractions, the heart of the distillation
consisting of the perfumed spirit, and the tails consisting of
unpalatable, empyreumatic phlegms (which are either
recycled or discarded). And while the use of water in the pot

Absinthe, Absinthism and Thujone The Open Addiction Journal, 2010, Volume 3 35
Fig. (4). The historic Combier distillery in Saumur, France, uses
two original 1870 alambics for the production of modern absinthe-
recreations.
aids in driving the distillation, the presence of ethanol causes
the vapor temperatures throughout the heart of the
distillation to remain relatively low, which improves the
exclusivity of the process and the organoleptic quality of the
product. This observation accounts for the difference in
content and flavor between an absinthe prepared from the
traditional spirituous re-distillation of herbs as opposed to
that cold-mixed from industrial (steam distilled) essences.
The lower distillation temperatures and exclusion of the
phlegms from the bottled product together constitute a
selective process in which a significant portion of thujone
from the macerate is omitted from the distillate. Finally, the
reduction from distillate strength (~80% Ethanol) to a bottled
strength of 60-72% for flagship products and 45-60% for
lesser grades, represents yet another significant reduction
(10-44%) in overall thujone content between the recovered
distillate and the finished product. All of these effects lead to
a significant reduction of thujone in the final spirit (see
summary in Fig. 5), so that the thujone content can only be
gathered by chemical analysis of the final beverage.
CHEMICAL ANALYSIS FINALLY PROVIDES THE
ANSWERS
When most of the world’s absinthe production was
effectively banned (1915), the state of the art of analytical
chemistry was far too primitive to clearly resolve debate
regarding the actual thujone content of the liquor. By the
time the analytical science became capable of resolvin g
questions concerning the content of absinthe, the liquor (and
lingering interest in it) had long since faded into obscurity.
Speculation regarding the content of vintage absinthe
persisted until beyond the end of the century, with published
claims of thujone concentrations of up to 260 mg/l [16]
commonly offered as fact and often repeated. Unfortunately,
these figures were the result of extrapolations of reported
herbal essential oil content, and in not one instance was data
obtained through actual laboratory analysis of the finished
liquor. The authors resolved some of this speculation in an
earlier study, specifically by conducting a literature review
on the composition of relevant species of wormwood (A.
Fig. (5). Steps of absinthe production and their influence on thujone recovery.
Wormwood herb
Maceration
Distillation
Colouration
Absinthe
Evaporation during drying for 6 months
Incomplete extraction
Accumulation in excluded tails fraction
Incomplete extraction
Thujone losses/reduction
Reduction with water to bottled strength
Bottling

36 The Open Addiction Journal, 2010, Volume 3 Lachenmeier et al.
absinthium and A. pontica), and finding that the levels of
thujone in the plants were previously overestimated [17].
The advent of gas chromatography (GC) combined with
mass spectrometry (MS), and commercially available
analytical standards, made it possible to develop
standardized methods for the detection of thujone for
regulators and researchers alike [18, 19]. Especially the use
of MS as detector was helpful for the identification of
thujone, when other terpenes are co-eluting (Fig. 6) [20].
Similarly, studies were conducted to resolve questions
regarding the toxicity and metabolic fate of thujone isomers
[21-23], which allowed researchers to gauge the actual
pharmacological potential of the compound. Eventually, the
last remaining question was if vintage absinthes contained a
higher amount of thujone than current, similarly prepared
products, and if other toxic compounds like methanol or
heavy metal salts were a factor in the vintage examples. Such
questions were left to debate until only recently [24]. The
total thujone content in 13 analyzed pre-ban samples was
found to range between 0.5 and 48.3 mg/L, while the
average thujone content of 25.4 ± 20.3 mg/L fell within the
modern Codex Alimentarius/European Union (EU) limit of
35 mg/L (which was derived from no-effect levels in animal
experiments with an additional safety factor). The authors
also provided evidence that thujone in bottled absinthe
remains stable, so that our analyses of hundred-year old
spirits were not confounded by significant thujone
deterioration over time [25]. From an analytical viewpoint,
these findings effectively exonerate absinthe of its sinister
reputation.
PUBLIC HEALTH POLICY ASPECTS
The re-legalization of absinthe in Europe can be traced
back to the Codex Alimentarius general requirements for
natural flavorings published in 1985, which allow the use of
flavorings containing thujone, up to certain maximum levels
(i.e. 10 mg/kg thujone in alcoholic beverages above 25% vol
and 35 mg/kg thujone in bitters) [26]. These general
requirements have been introduced into the laws of many
countries, including the EU [27]. The European regulation
has recently been amended such that the 35 mg/kg limitation
applies to all Artemisia-derived alcoholic beverages (and not
only bitters) [28]. So far, the USA has not introduced the
Codex Alimentarius recommendations for thujone into its
law. However, a historical milestone was observed in 2007,
when the US government approved the first genuine
absinthes for US distribution since 1912. The US
government concluded that finished spirits that exhibit <10
Fig. (6). GC-MS chromatogram of an absinthe sample with identification of terpenes. Insert: mass sp ectrum of -thujone.
3.2
3.0
2.8
2.6
2.4
2.2
2.0
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
78910
11 12 13 14 15
Time (min)
12.26 12.63
14.56
10.00
10.20
9.42
9.13
b-thujone
a-thujone
fenchone
8.66
8.17
7.95
7.25
7.06
a-thujone
linalool
8.96
10.43
11.04 13.11 13.68 14.12
Relative Abundance
35
30
25
20
15
10
5
0
50.9
52.9
54.9
67.0
64.9
68.0
78.9
76.9
81.0
82.0
83.0
90.9
95.0
96.0
105.0
109.0
119.0
124.0 134.0 141.0
152.0
154.1 166.0
110.0
110.0
Relative Abundance

Absinthe, Absinthism and Thujone The Open Addiction Journal, 2010, Volume 3 37
mg/l thujone effectively satisfy the FDA’s ‘thujone-free’
requirement [29, 30]. This stance was adopted in accordance
with the Codex Alim entarius recommendation with respect
to thujone content in finished spirits, and represents not a
change in the US legal code, but rather an acknowledgement
that an indicated thujone content of <10 mg/l is far too small
to present any genuine public health concerns.
CONCLUSIONS
In conclusion, the authors want to point to a potential
public health issue of greater concern than incidental thujone
content, which lies in the tendency for some modern
marketers to take advantage of age-old myths to promote
their products as delivering an experience akin to that of
illicit drugs. Many advertisements that appear both online
and in print make obvious references to claimed thujone
content and hint strongly of psychotropic effects beyond the
ones of ethanol alone (e.g. effects similar to Cannabis) or
claim alleged aphrodisiac properties for the spirit [7]. Such
marketing strategies increase the appeal of these products to
a younger audience, which presents far more fertile grounds
for abuse. A commonly purported misconception is also the
claim that thujone in absinthe acts as antagonist on the action
of ethanol, so that the drinker allegedly can tolerate a higher
amount of ethanol without experiencing adverse effects. This
may lead to a trivialization of alcohol-related harms and
could have grave health consequences, e.g. if the consumers
misjudge their driving abilities.
It has become evident th at a significant percentage of
consumers and potential consumers want the myths about the
psychotropic properties of absinthe to be true, even in the
face of co mpelling evidence that they are not. For these
consumers, absinthe, without its drug like allure, is no longer
interesting. In this misapprehension they are encouraged by a
handful of unscrupulous manufacturers who continue to
hype the thujone myth. For example, in a recently published
survey of spirits marketed under the designation ‘absinthe’
over the internet, thujone was detected in amounts
significantly exceeding the maximum limits in three of five
products purchased for analysis (Table 1). The products were
advertised and intentionally manufactured for ‘high-thujone
content” using either pure thujone, cedar leaf oil or
artificially high amounts of wormwood oil. Such
unscrupulous marketers apparently use the anonymity of the
internet to sell their ‘drug-like’ absinthes based on
completely false claims [31].
Considering that many of the products in question are
also significantly higher in alcohol content as compared to
most commercial spirits, the potential for alcohol abuse in
those seeking a drug-like experience is uncomfortably high.
Already, US regulators have taken a stand against such
marketing practices, and staunchly prohibit references to
thujone and drug-like effects in product literature. Clearly
the potential for abuse can be mitigated by a more
widespread adoption of similar advertising rules by
regulators in the EU, and elsewhere. These should include
effective control of the sale of alcoholic beverages over the
internet.
REFERENCES
[1] Lachenmeier DW, Walch SG, Padosch SA, et al. Absinthe - A
review. Crit Rev Food Sci Nutr 2006; 46: 365-77.
[2] Lachenmeier DW, Frank W, Athanasakis C, et al. Absinthe, a spirit
drink - its history and future from a toxicological-analytical and
food regulatory point of view. Deut Lebensm-Rundsch 2004; 100:
117-29.
[3] Bostock J, Riley HT, Eds. Pliny the Elder: Book XXVII. Chap. 28.
Absinthium or wormwood. The natural history. London, UK:
Taylor and Francis 1855.
[4] Nathan-Maister D. The absinthe encyclopedia. Burgess Hill, UK:
Oxygéneé Press 2008.
[5] Delachaux PA. L'Absinthe au Val-de-Travers: recherches sur ses
origines. Revue Historique Neuchateloise 1997; 1/97: 3-22.
[6] Couleru E. Au pays de l'absinthe, y est-on plus criminel qu'ailleurs,
ou moins sain de corps et d'esprit? Un peu de statistique SVP. In
the country of absinthe, are people more criminal than elsewhere or
less sound in body or mind? A few statistics please. France:
Montbéliard 1908.
[7] Padosch SA, Lachenmeier DW, Kröner LU. Absinthism: a
fictitious 19 th century syndrome with present impact. Subst Abuse
Treat Prev Policy 2006; 1: 14.
[8] Motet A. Considérations générales sur l'alcoolisme et plus
particulièrement des effets toxiques produits par la liqueur
d'absinthe. Paris, France: Thèse pour le doctorat en médecine 1859.
[9] Luauté JP. L'absinthisme: la faute du docteur Magnan. Absinthism:
the fault of doctor Magnan. Evol Psychiatr 2007; 72: 515-30.
[10] Magnan V. Accidents déterminés par l'abus de la liqueur
d'absinthe. Union Med 1864; 92&94: 227-32&257-62.
[11] Marcé LV. Sur l'action toxique de l'essence d'absinthe. C R Acad
Sci 1864; 58: 628-9.
[12] Magnan V. On the comparative action of alcohol and absinthe.
Lancet 1874; 104: 410-2.
[13] Lachenmeier DW, Kuballa T. Behaviour of thujone during
distillation and possible concentration ranges in pre-ban absinthe. J
Sci Food Agric 2007; 87: 2147-51.
[14] Dentu, E. Maison Pernod Fils á Pontarlier (Doubs). Paris, France
(available online:
http://www.oxygenee.com/absinthe/books1.html): 1896.
[15] Duplais P. A treatise on the manufacture and distillation of
alcoholic liquors - facsimile of the 1871 English edition. In:
Nathan-Maister D, Ed. Burgess Hill, UK: Oxygéneé Press 2008.
Table 1. Analysis Results of Spirits with the Designation ‘Absinthe’ Exclusively Marketed Over the Internet (Data Summarized
from Löb ell-Behrends et al. [31])
Labeled Alcohol ic
Strength ( % vol)
Analyzed Alcoholic
Strength ( % vol)
Labeled T hujone Content Analyze d Thujone
Content (GC/MS) ( mg/kg)
Absinthe 1 70 70.1 (not specified) 0.6
Absinthe 2 (not specified) 65.4 100 mg/kg (according to internet advertisement) 126 *
Absinthe 3 70 68.4 ‘Contains 90 mg’ 0.4
Absinthe 4 70 54.8 100 mg/l 57 *
Absinthe 5 55 54.8 100 mg/kg 119 *
*Thujone content in exceedance of legal limit of 35 mg/kg. The products are not allowed to be marketed in the European Union.

38 The Open Addiction Journal, 2010, Volume 3 Lachenmeier et al.
[16] Strang J, Arnold WN, Peters T. Absinthe: what's your poison? Br
Med J 1999; 319: 1590-2.
[17] Lachenmeier DW, Nathan-Maister D. Systematic misinformation
about thujone in pre-ban absinthe. Deut Lebensm-Rundsch 2007;
103: 255-62.
[18] Bestimmung des Thujons, gaschromatographisch. Manuel suisse
des denrées alimentaires. Berne, Switzerland: Office fédéral de la
santé publique 2000; vol. 32/13: pp. 1-3.
[19] Rapp A, Hastrich H, Yavas I, et al. Zur einfachen, schnellen
Anreicherung ("Kaltronmethode") und quantitativen Bestimmung
von flüchtigen Inhaltsstoffen aus Spirituosen: Bestimmung von
Thujon, Safrol, Isosafrol, -Asaron, Pulegon und Cumarin.
Branntweinwirtsch 1994; 134: 286-9.
[20] Emmert J, Sartor G, Sporer F, et al. Determination of -/-thujone
and related terpenes in absinthe using solid phase extraction and
gas chromatography. Deut Lebensm-Rundsch 2004; 100: 352-6.
[21] Höld KM, Sirisoma NS, Casida JE. Detoxification of - and -
Thujones (the active ingredients of absinthe): site specificity and
species differences in cytochrome P450 oxidation in vitro and in
vivo. Chem Res Toxicol 2001; 14: 589-95.
[22] Meschler JP, Howlett AC. Thujone exhibits low affinity for
cannabinoid receptors but fails to evoke cannabimimetic responses.
Pharm Biochem Behav 1999; 62: 473-80.
[23] Lachenmeier DW, Emmert J, Kuballa T, et al. Thujone-cause of
absinthism? Forensic Sci Int 2006; 158: 1-8.
[24] Lachenmeier DW, Nathan-Maister D, Breaux TA, et al. Chemical
composition of vintage preban absinthe with special reference to
thujone, fenchone, pinocamphone, methanol, copper, and antimony
concentrations. J Agric Food Chem 2008; 56: 3073-81.
[25] Lachenmeier DW, Nathan-Maister D, Breaux TA, et al. Long-term
stability of thujone, fenchone, and pinocamphon e in vintage preban
absinthe. J Agric Food Chem 2009; 57: 2782-5.
[26] Codex alimentarius. General requirements for natural flavourings
(CAC/GL 29.1987). 1985; www.codexalimentarius.net [Accessed
on: 2007/10/17].
[27] Council Directive (EEC) No 88 /388 on the approximation of the
laws of the Member States relating to flavourings for use in
foodstuffs and to source materials for their production. Off J Eur
Commun 1988; L184: 61-6.
[28] European Parliament and Council. Regulation (EC) No 1334/2008
of the European Parliament and of the Council of 16 December
2008 on flavourings and certain food ingredients with flavouring
properties for use in and on foods and amending Council
Regulation (EEC) No 1601/91, Regulations (EC) No 2232/96 and
(EC) No 110/2008 and Directive 2000/13/EC. Off J Eur Union
2008; L354: 34-50.
[29] FDA. Code of Federal Regulations - 21CFR172.510. 2009;
www.gpoacce ss.gov/cfr [Accessed on: 2009/06/30].
[30] Alcohol and Tobacco Tax and Trade Bureau. Industry Circular
Number 2007-5. Use of the term absinthe for distilled spirits. 2007;
http://www.ttb.gov/industry_circulars/archives/2007/07-05.html
[Accessed on: 2009/06/30].
[31] Löbell-Behrends S, Kuballa T, el-Atma O, et al. Internet marketing
and the advertisement of alcoholic beverages: a failure of industry
self-regulation? Sucht 2008; 54: 346-53.
Received: June 30, 2009 Revised: December 4, 20092009 Accepted: December 4, 2009
© Lachenmeier et al.; Licensee Bentham Open.
This is an open access article licen sed under the terms of the Creative Commons Attribution Non -Commercia l License (http://creativecommons.org/licenses /by-
nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.